Randox Clinical Toxicology MultiSTAT 318
Randox Clinical Toxicology MultiSTAT

Randox Clinical Toxicology MultiSTAT Biochip is an advanced multiplex testing solution designed to support rapid, accurate and comprehensive clinical toxicology screening from a single patient sample. Developed using Randox’s patented Biochip Array Technology, the system enables simultaneous detection of multiple drugs and metabolites in urine, blood and oral fluid, supporting fast and informed clinical decision-making in acute care settings.

Designed for use in hospitals, emergency departments and clinical laboratories, the MultiSTAT Biochip can detect a wide range of substances including drugs of abuse, prescription medications and synthetic drugs, delivering semi-quantitative results in under 30 minutes. The technology supports a variety of clinical toxicology applications including overdose assessment, toxicology investigations, therapeutic monitoring and patient management, helping clinicians rapidly identify potential toxic substances and guide appropriate treatment decisions.

At the core of the system is the Evidence MultiSTAT analyser, a compact and fully automated platform requiring minimal sample preparation and limited operator input. Using chemiluminescent immunoassay technology and advanced image processing software, the system delivers highly sensitive and reliable multi-analyte detection while simplifying laboratory workflow and reducing turnaround times.

By combining rapid multiplex testing with broad drug detection capabilities and ease of use, the Randox Clinical Toxicology MultiSTAT Biochip provides healthcare providers and laboratories with an efficient and dependable solution for modern clinical toxicology screening and patient care.

Category Press Releases